Riskpilot← Back to searchSign inGet full accessDanderyds läkarhus AB
ABActiveOrg 5568729114Vendevägen 90Medical specialists activities · NACE 8622Est. 20114 employees
Revenue 2024
SEK 4,8M
+12% vs 2023
EBITDA margin
0.7%
-83% vs 2023
Equity ratio
33.4%
Financial strength
Net profit 2024
SEK -6K
-103% vs 2023
| Revenue | SEK 4,8M | +12% |
| EBITDA | SEK 34K | -83% |
| Net profit | SEK -6K | -103% |
| Total assets | SEK 1,3M | +98% |
| Equity | SEK 429K | -1% |
| Employees | 4 | — |
Legal name
Danderyds läkarhus AB
Org number
5568729114
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
23 november 2011
Share capital
SEK 50 000
Employees
4 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolagets verksamhet skall vara att direkt eller indirekt, på uppdrag eller i egen regi, med egen personal eller inhyrda konsulter, bedriva sjuk- och hälsovård och omsorg, samt rehabiliterings-, behandlings- och rekreationsverksamhet, bedriva hotellverksamhet, förvaltning av fastigheter och uthyrning av lokaler och tjänster inom området, äga och förvalta värdepapper och annan lös egendom samt idka därmed förenliga verksamheter.
Address
Vendevägen 90
Phone
+46708733300
Email
info@strandkliniken.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 6 355 | 5 357 | 5 695 | 4 308 | 4 821 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 836 | −839 | 130 | 200 | 34 |
| Depreciation & amort. | −34 | −54 | −34 | −24 | −24 |
| EBIT | 1 802 | −893 | 96 | 176 | 10 |
| Net financials | — | −60 | −5 | — | −16 |
| Profit before tax | 1 802 | −1 023 | 91 | 176 | −6 |
| Tax | −386 | −0 | −0 | −0 | −0 |
| Net profit | 1 416 | −1 023 | 91 | 176 | −6 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 055 | 1 059 | 776 | 649 | 1 286 |
| Equity | 1 471 | 447 | 538 | 434 | 429 |
| Long-term debt | 0 | 0 | 1 | 19 | 264 |
| Short-term debt | 584 | 612 | 237 | 195 | 594 |
| Total debt | 584 | 612 | 238 | 214 | 858 |
EBITDA margin
0.7%
This company
15.8%
Market median
-96% vs market
20202024
Equity ratio
33.4%
This company
38.2%
Market median
+13% vs market
20202024
Return on equity
-1.4%
This company
18.4%
Market median
-108% vs market
20202024
Net profit margin
-0.1%
This company
8.1%
Market median
-101% vs market
20202024
Asset turnover
3.75×
This company
1.12×
Market median
+235% vs market
20202024
Debt / equity
2.00×
This company
0.62×
Market median
-223% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
LK Audit | Audit | 2022 |
AK Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2020 | |
| Chairman | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Danderyds läkarhus AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Kenneth Elton | Audit | 0 companies |
| Alan Kenneth Blake | Chief Executive Officer | 0 companies |
| Jan-Olof Christer Degerbalkan | Deputy Board Member | 0 companies |
| Oya Degerbalkan | Chairman | 0 companies |